A Phase 1 Clinical Trial to Explore Systemic Exposure of CTO0101 Eye Drops, Safety and Local Tolerability in Healthy Adults

NCT05262179 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: CTO0101
OTHER: Placebo (vehicle)

Sponsor

Taejoon Pharmaceutical Co., Ltd.